FAQ/Help |
Calendar |
Search |
Today's Posts |
05-08-2015, 07:20 PM | #1 | ||
|
|||
Magnate
|
|
||
Reply With Quote |
"Thanks for this!" says: | lab rat (05-09-2015) |
05-09-2015, 09:12 AM | #2 | ||
|
|||
Senior Member
|
Quote:
|
||
Reply With Quote |
05-09-2015, 09:24 AM | #3 | ||
|
|||
Magnate
|
Quote:
http://www.pharmacologyweekly.com/ar...kinson-disease you would think you could just take oral carbidopa. |
||
Reply With Quote |
"Thanks for this!" says: | lurkingforacure (05-09-2015) |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
NeuroDerm Announces Positive Topline Results of Phase II Trials | Parkinson's Disease | |||
NeuroDerm Announces Enrollment in a 2nd Phase 2 Study of ND0612 - Continuous L/C Drug | Parkinson's Disease | |||
NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In | Parkinson's Disease | |||
NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Ca | Parkinson's Disease | |||
NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Ca | Parkinson's Disease |